VALEANT Email Format
Pharmaceutical Manufacturing51-200 Employees
Valeant Pharmaceuticals International, Inc. operates as a diversified, decentralized pharmaceutical company that aims to deliver consistent performance for its stakeholders. Its stated values provide direction and support in meeting challenges through teamwork and a competitive spirit. The company is part of the pharmaceutical manufacturing industry and is based in Canada, with a mid-sized workforce. This structure reflects a focus on stakeholder engagement and sustained performance. In 2022, Valeant launched flibanserin (Addyi) in the U.S. market following its acquisition of Sprout Pharmaceuticals.